Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | $2.6 | $2.9 | $3.5 | $4.1 | $4.6 | $5.0 | $5.5 | $5.3 | $6.2 | $6.7 | $6.0 | $4.4 | $7.1 | $12.4 | $8.7 | $8.4 | $16.0 | $24.6 | $14.0 | $4.8 |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Laboratory Corporation of America Holdings's last 12-month EPS is $5.2, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Laboratory Corporation of America Holdings's EPS growth was (30.9%). The average annual EPS growth rates for Laboratory Corporation of America Holdings have been (42.3%) over the past three years, (7.5%) over the past five years.
Over the last year, Laboratory Corporation of America Holdings's EPS growth was (30.9%), which is lower than industry growth of (0.2%). It indicates that Laboratory Corporation of America Holdings's EPS growth is Bad.